CHICAGO, May 01, 2018 -- Lumere, a leading provider of data-driven analytics, evidence and expert guidance to help health systems reduce unwarranted clinical variation, today announced plans to collaborate with the Association of Healthcare Value Analysis Professionals’ (AHVAP) Industry Business Education Collaborative agreement.
This agreement includes educational offerings highlighting best-practice strategies and tactics to help health systems and value analysis professionals consistently apply evidence to clinical decisions. “Hospitals and clinicians are strapped to find the time and the resources to collect the vast amounts of available drug and device information and also to dissect and separate unbiased sources from biased ones,” said Lumere Chief Development Officer Gina Thomas, RN, MBA. “AHVAP is the perfect collaborator because of its dedication to applying a clinical and evidence-based perspective to the clinical decision process.”
According to AHVAP President Susan Knapp, RN, MS, CVAHP, the two organizations share a vision to improve patient value by reducing unnecessary clinical variation and reducing costs. “Variation in care is a major contributor to wasteful healthcare spending,” she said. “Our members have the potential to play important roles in curtailing that waste, and solutions like Lumere’s offer important resources for them and their facilities.”
According to Knapp, redefining and repositioning the role of value analysis offers an exceptional opportunity to bring about real change.
“Historically, value analysis leaders have had to react quickly to market place pressures. While that doesn’t change, integrating a clinical and evidence-based approach metric into all decisions will help advance the value analysis practice,” Knapp said.
Thomas, agrees with that assessment. “Our educational offerings will emphasize the fact that value analysis must be embedded within an organization’s clinical care governance as a patient-centered, multidisciplinary approach,” she said.
About Lumere
Lumere is at the forefront of clinical decision making for drugs and devices, offering evidence-based solutions and services for all providers that improve care and reduce cost across the patient journey. For more information, visit lumere.com, find us on LinkedIn, follow @LumereHQ on Twitter and like us on Facebook.
About AHVAP
The Association of Healthcare Value Analysis Professionals (AHVAP) is an organization of professionals whose expertise bridges the gap between clinical and supply chain process. Through the use of evidence, clinical and financial expertise value analysis facilitators play a pivotal role to ensure effective decision-making that positively impacts clinical, operational and financial outcomes. For more information, visit AHVAP.org, find us on LinkedIn, follow @AHVAP on Twitter and like us on Facebook.
Media Contact
Pam Flores
[email protected]
(773) 218-9260


OpenAI GPT-5.6 Set for Wider Release After U.S. Commerce Approval, Report Says
Samsung Chairman Lee Jae-yong Expected to Meet Nvidia CEO Jensen Huang on AI and Chip Partnership
SK Hynix’s $28 Billion U.S. Share Sale Draws Massive Demand Amid AI Chip Boom
SK Hynix’s $28B U.S. IPO Draws Strong Demand as AI Chip Boom Fuels Investor Interest
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth
Netflix, Disney, YouTube Eye FIFA World Cup TV Rights in Multi-Billion Dollar Battle
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy
Bernstein Names IAG, Ryanair as Top European Airline Stocks Ahead of Earnings
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft
Wolfspeed Sues Navitas Over GaN and SiC Patent Infringement
Elon Musk Says Anthropic Leads AI Race as Claude Models Challenge OpenAI
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO
Apple Tests China's CXMT Memory Chips as DRAM Maker Gains Global Market Share
Mizuho’s Top U.S. Industrials Stocks: Why Corteva and Stanley Black & Decker Stand Out 



